Nghĩa của từ dopaminergic bằng Tiếng Anh

adjective

1

releasing or involving dopamine as a neurotransmitter. Drugs with this effect are used in the treatment of Parkinson's disease and some psychiatric disorders; some are subject to abuse.

Its primary actions alter both the dopaminergic and the opioid systems as well as other neurotransmitter systems.

Đặt câu với từ "dopaminergic"

1. The small molecules provided herein modulate dopaminergic neuronal activity.

2. Both PKC and cAMP signaling contribute to dopaminergic inhibition of NHE3 and Na+,K+ pump.

3. Anorectics stimulate both the beta and dopaminergic receptors in the CNS and we get appetite suppression

4. The dopaminergic pathways are associated with reward, attention, short-term memory tasks, planning, and motivation.

5. Nausea, also related to enhanced central dopaminergic activity, is a common adverse reaction of levodopa/carbidopa

6. dopaminergic compounds are useful in the treatment of schizophrenia, Parkinson's disease, Tourette's syndrome, and drug or alcohol addiction.

7. Further studies on these mutants will advance understanding of the calcium-handling mechanisms and dopaminergic neuroprotection in general.

8. All eight reconstructed tyrosine hydroxylase-positive dopaminergic neurons possessed widely spread and highly dense axonal Arborizations in the neostriatum.

9. Symptoms suggestive of neuroleptic malignant syndrome have been reported with abrupt withdrawal of dopaminergic therapy (see section

10. Guo et al., 2002, Apomorphine induces trophic factors that support fetal rat mesencephalic dopaminergic neurons in cultures., Eur

11. Objective To observe the distribution of dopaminergic cerebrospinal fluid-contacting neurons (CSF-CNs) in the third ventricle and the mesencephalic aqueduct of rat.

12. Apomorphine is a potent D1 and D2 dopaminergic agonist and is administered through subcutaneous injection at doses from 15 to 180 μg/kg

13. Tổng quát Apomorphin là một thành phần hoạt động có khả năng tác động mạnh đến dopaminergic

14. Opium Alkaloids activate the mesocorticolimbic dopaminergic system, which project from the ventral tegmental area to the nucleus accumbens and medial prefrontal cortex, and dopamine is critically important in opioid consumption …

15. Application or stimulation of growth factors and/or transplantation of neuronal dopaminergic cells, may redirect Parkinsonian therapy from present palliative, symptomatic therapeutic principles to Acurative therapy in the future

16. Either D 2 or D 3 antisense oligodeoxynucleotides greatly attenuated the ability of apomorphine to inhibit dopaminergic neurons in vivo, an effect that was potentiated by simultaneous administration of D 2 and D 3 Antisenses

17. Apomorphine is a type of dopaminergic agonist, a morphine derivative (but does not actually contain morphine, or bind to opioid receptors).Apomorphine is a relatively non-selective dopamine receptor agonist, having possible slightly higher affinity for D 2-like dopamine receptors.

18. Adrenergic Receptors Located throughout the body Are receptors for the sympathetic neurotransmitters o α-Adrenergic receptors o ß-Adrenergic receptors o Dopaminergic receptors: respond only to dopamine This is important with Parkinson's – with Parkinson's there is a lack of dopamine α-Adrenergic Agonist Responses Vasoconstriction Central

19. In this review, various studies will be considered which proffer converging evidence that the dopaminergic brain circuitry running from ventral tegmental areas in the midbrain, via nucleus accumbens in the forebrain, to the frontal cortex, tends to produce Aboulia when its restitutive function fails.

20. Apomorphine (sublingual/ injection) Generic name: Apomorphine (sublingual/ injection) (a poe MOR feen) Brand name: Apokyn, Kynmobi, APO-Go, APO-Go Pen, Uprima Dosage forms: subcutaneous solution (10 mg/mL); sublingual film (10 mg; 10 mg-15 mg-20 mg-25 mg-30 mg; 15 mg; 20 mg; 25 mg; 30 mg) Drug class: Dopaminergic antiparkinsonism agents Medically reviewed by Drugs.com …

21. The invention relates to a device (100) comprising a generator unit (1) for generating stimulation signals and a stimulation unit (2) connected to the generator unit (1), wherein the stimulation unit (2) is designed to stimulate nerve cells (3) in the nucleus accumbens and/or in the amygdaloid nucleus and/or in the fasciculus medialis telencephali and/or in pathways made of dopaminergic areas of the mesencephalon leading to the nucleus accumbens or the amygdaloid nucleus and/or in fibre bundles that connect the nucleus accumbens and the amygdaloid nucleus using said stimulation signals.